Keap1 controls protein S-nitrosation and apoptosis-senescence switch in endothelial cells
Aleksandra Kopacz,
Damian Klóska,
Bartosz Proniewski,
Dominik Cysewski,
Nicolas Personnic,
Aleksandra Piechota-Polańczyk,
Patrycja Kaczara,
Agnieszka Zakrzewska,
Henry Jay Forman,
Józef Dulak,
Alicja Józkowicz,
Anna Grochot-Przęczek
Affiliations
Aleksandra Kopacz
Department of Medical Biotechnology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, 30-387, Krakow, Poland
Damian Klóska
Department of Medical Biotechnology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, 30-387, Krakow, Poland
Bartosz Proniewski
Jagiellonian Centre for Experimental Therapeutics, Jagiellonian University, 30-348, Krakow, Poland
Dominik Cysewski
Mass Spectrometry Laboratory, Institute of Biochemistry and Biophysics, Polish Academy of Science, 02-106, Warsaw, Poland
Nicolas Personnic
Department of Medical Biotechnology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, 30-387, Krakow, Poland
Aleksandra Piechota-Polańczyk
Department of Medical Biotechnology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, 30-387, Krakow, Poland
Patrycja Kaczara
Jagiellonian Centre for Experimental Therapeutics, Jagiellonian University, 30-348, Krakow, Poland
Agnieszka Zakrzewska
Jagiellonian Centre for Experimental Therapeutics, Jagiellonian University, 30-348, Krakow, Poland
Henry Jay Forman
Andrus Gerontology Center of the Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, 90089-0191, USA
Józef Dulak
Department of Medical Biotechnology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, 30-387, Krakow, Poland; Malopolska Centre of Biotechnology, Jagiellonian University, 30-387, Krakow, Poland
Alicja Józkowicz
Department of Medical Biotechnology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, 30-387, Krakow, Poland
Anna Grochot-Przęczek
Department of Medical Biotechnology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, 30-387, Krakow, Poland; Corresponding author. Department of Medical Biotechnology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387, Krakow, Poland.
Premature senescence, a death escaping pathway for cells experiencing stress, is conducive to aging and cardiovascular diseases. The molecular switch between senescent and apoptotic fate remains, however, poorly recognized. Nrf2 is an important transcription factor orchestrating adaptive response to cellular stress. Here, we show that both human primary endothelial cells (ECs) and murine aortas lacking Nrf2 signaling are senescent but unexpectedly do not encounter damaging oxidative stress. Instead, they exhibit markedly increased S-nitrosation of proteins. A functional role of S-nitrosation is protection of ECs from death by inhibition of NOX4-mediated oxidative damage and redirection of ECs to premature senescence. S-nitrosation and senescence are mediated by Keap1, a direct binding partner of Nrf2, which colocalizes and precipitates with nitric oxide synthase (NOS) and transnitrosating protein GAPDH in ECs devoid of Nrf2. We conclude that the overabundance of this “unrestrained” Keap1 determines the fate of ECs by regulation of S-nitrosation and propose that Keap1/GAPDH/NOS complex may serve as an enzymatic machinery for S-nitrosation in mammalian cells. Keywords: Keap1, NOX4, Nrf2, Oxidative stress, S-nitrosation, S-nitrosylation